Polyphenols and aging

Current Aging Science

Volumn 3, Issue 1, 2010, Pages 34-42

  Queen, Brannon L ^a   Tollefsbol, Trygve O ^a,b  

^a Department of Biology ^*  (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Aging; Alzheimer's disease; Angiogenesis; Cancer; Neuroprotection; Polyphenols; SIRT1

Indexed keywords

CURCUMIN; EPIGALLOCATECHIN GALLATE; POLYPHENOL DERIVATIVE; QUERCETIN; REACTIVE OXYGEN METABOLITE; RESVERATROL; SIRTUIN 1;

AGING; ALZHEIMER DISEASE; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR FUNCTION; CELL DAMAGE; DRUG MECHANISM; HUMAN; INFLAMMATION; NEOPLASM; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; VASCULAR DISEASE;

AGING; ALZHEIMER DISEASE; ANIMALS; CARDIOVASCULAR PHYSIOLOGICAL PHENOMENA; FLAVONOIDS; HUMANS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PHENOLS; RISK FACTORS;

EID: 77953762857     PISSN: 18746098     EISSN: 18746128     Source Type: Journal    
DOI: 10.2174/1874609811003010034     Document Type: Article

References (106)

1. Di Giulio C, Antosiewicz J, Walski M, Petruccelli G, Verratti V, Bianchi G,et al. Physiological carotid body denervation during aging. Adv Exp Med Biol 2009; 648: 257-63.
2. Weinberg EJ, Schoen FJ, Mofrad MR. A computational model of aging andcalcification in the aortic heart valve. PLoS One 2009; 4: e5960.
3. Haase H, Rink L. The immune system and the impact of zinc during aging. Immun Ageing 2009; 6: 9.
4. Wagner W, Bork S, Horn P, Krunic D, Walenda T, Diehlmann A, et al. Aging and replicative senescence have related effects on human stem andprogenitor cells. PLoS One 2009; 6: e5846.
5. Modrick ML, Didion SP, Sigmund CD, Faraci FM. Role of oxidative stressand AT(1) receptors in cerebral vascular dysfunction with aging. Am JPhysiol Heart Circ Physiol 2009; 296: H1914-1919.
6. Ikonomovic MD, Wecker L, Abrahamson EE, DeKosky ST. Cortical α7 nicotinic acetylcholine receptor and β-amyloid levels in early alzheimerdisease. Arch Neurol 2009; 66: 646-651.
7. Anisimov VN, Sikora E, Pawelec G. Relationships between cancer andaging: a multilevel approach. Biogerontology 2009; 10: 323-38.
8. Weinreb O, Mandel S, Amit T, Moussa BHY. Nuerological mechanisms ofgreen tea polyphenol's in Alzheimer's and Parkinson's Disease. J Nutr Biochem 2004; 15: 506-16.
9. Levites Y, Amit T, Mandel S, Youdim MB. Neuroprotection andneurorescue against Abeta toxicity and PKC-dependent release ofnonamyloidogenic soluble precursor protein by green tea polyphenol (-)-epigallocatechin-3-gallate. FASEB J 2003; 17: 952-4.
10. Dowling DK, Simmons LW. Reactive oxygen species as universalconstraints in life-history evolution. Proc Biol Sci 2009; 276: 1737-45.
11. Roux AE, Leroux A, Alaamery MA, Hoffman CS, Chartrand P, Ferbeyre G, et al. Proaging effects of glucose signaling through a G protein-coupledglucose receptor in fission yeast. PLoS Genet 2009; 5: e1000408.
12. Patlolla AK, Barnes C, Yedjou C, Velma VR, Tchounwou PB. Oxidativestress, DNA damage, and antioxidant enzyme activity induced by hexavalentchromium in Sprague-Dawley rats. Environ Toxicol 2009; 24: 66-73.
13. Zhang X, Cao J, Jiang L, Zhong L. Suppressive effects of hydroxytyrosol onoxidative stress and nuclear Factor-kappaB activation in THP-1 cells. BiolPharm Bull 2009; 32: 578-82.
14. Pauwels EK, Erba PA, Kostkiewicz M. Antioxidants: a tale of two stories.Drug News Perspect 2007; 20: 579-85.
15. Parsons PA. The ecological stress theory of aging and hormesis: an energeticevolutionary model. Biogerontology 2007; 8: 233-42.
16. Rossi L, Mazzitelli S, Arciello M, Capo CR, Rotilio G. Benefits from dietarypolyphenols for brain aging and Alzheimer's disease. Neurochem Res 2008;33: 2390-400.
17. Sondag CM, Combs CK. Amyloid precursor protein cross-linking stimulatesamyloid production and pro-inflammatory cytokine release in monocyticlineage cells. J Neurochem 2006; 97: 449-61.
18. Zhang YM, Herbert BS, Rajashekhar G, Ingram DA, Yoder MC, Clauss M, et al. Premature senescence of highly proliferative endothelial progenitorcells is induced by tumor necrosis factor-alpha via the p38 mitogen-activatedprotein kinase pathway. FASEB J 2009; 23: 1358-65.
19. Kwong J, Chan FL, Wong KK, Birrer MJ, Archibald KM, Balkwill FR, et al. Inflammatory cytokine tumor necrosis factor confers precancerousphenotype in an organoid model of normal human ovarian surface epithelialcells. Neoplasia 2009; 11: 529-41.
20. McKellar GE, McCarey DW, Sattar N, McInnes IB. Role for TNF inatherosclerosis? Lessons from autoimmune disease. Nat Rev Cardiol 2009; 6:410-17.
21. Aggarwal BB, Bhardwaj A, Aggarwal RS, Seeram NP, Shishodia S, TakadaY. Role of resveratrol in prevention and therapy of cancer: preclinical andclinical studies. Anticancer Res 2004; 24: 2783-840.
22. Sethi G, Sung B, Aggarwal BB. Nuclear factor- B activation: from bench tobedside. Exp Biol Med 2008; 233: 21-31.
23. Glukhov IL, Sirota NP, Kuznetsova EA. DNA damage in humanmononuclear cells induced by bacterial endotoxin. Bull Exp Biol Med 2008;146: 301-3.
24. Sebai H, Ben-Attia M, Sani M, Aouani E, Ghanem-Boughanmi N. Protectiveeffect of resveratrol in endotoxemia-induced acute phase response in rats.Arch Toxicol 2009; 83: 335-40.
25. Adlard PA, James SA, Bush AI, Masters CL. β-Amyloid as a moleculartherapeutic target in Alzheimer's disease. Drugs Today (Barc) 2009; 45: 293-304.
26. Hajieva P, Kuhlmann C, Luhmann HJ, Behl C. Impaired calciumhomeostasis in aged hippocampal neurons. Neurosci Lett 2009; 451: 119-23.
27. Sun AY, Simonyi A, Sun GY. The French paradox and beyond:neuroprotective effects of polyphenols. Free Radic Biol Med 2002; 32: 314-18.
28. Büttemeyer R, Philipp AW, Schlenzka L, Mall JW, Beissenhirtz M, Lisdat F.Epigallocatechin gallate can significantly decrease free oxygen radicals inthe reperfusion injury in vivo. Transplant Proc 2003; 35: 3116-20.
29. Suzuki J, Ogawa M, Sagesaka YM, Isobe M. Tea catechins attenuateventricular remodeling and graft arterial diseases in murine cardiacallografts. Cardiovasc Res 2006; 69: 272-79.
30. Stangl V, Dreger H, Stangl K, Lorenz M. Molecular targets of teapolyphenols in the cardiovascular system. Cardiovasc Res 2007; 73: 348-58.
31. Townsend PA, Scarabelli TM, Pasini E, Gitti G, Menegazzi M, Suzuki H, et al. Epigallocatechin-3-gallate inhibits STAT-1 activation and protectscardiac myocytes from ischemia/reperfusion-induced apoptosis. FASEB J 2004; 18: 1621-1623.
32. Paquay JB, Haenen GR, Stender G, Wiseman SA, Tijburg LB, Bast A.Protection against nitric oxide toxicity by tea. J Agric Food Chem 2000; 48:5768-5772.
33. Benitez DA, Hermoso MA, Pozo-Guisado E, Fernández-Salguero PM, Castellón EA. Regulation of cell survival by resveratrol involves inhibitionof NF kappa B-regulated gene expression in prostate cancer cells. Prostate 2009; 69: 1045-1054.
34. Siddiqui IA, Shukla Y, Adhami VM, Sarfaraz S, Asim M, Hafeez BB, et al. Suppression of NFkappaB and its regulated gene products by oraladministration of green tea polyphenols in an autochthonous mouse prostatecancer model. Pharm Res 2008; 25: 2135-42.
35. Meeran SM, Akhtar S, Katiyar SK. Inhibition of UVB-induced skin tumordevelopment by drinking green tea polyphenols is mediated through DNArepair and subsequent inhibition of inflammation. J Invest Dermatol 2009;129: 1258-1270.
36. Sun AY, Wang Q, Simonyi A, Sun GY. Botanical phenolics and brainhealth. Neuromol Med 2008; 10: 259-274.
37. Ramos S. Cancer chemoprevention and chemotherapy: dietary polyphenolsand signalling pathways. Mol Nutr Food Res 2008; 52: 507-526.
38. Bureau G, Longpré F, Martinoli MG. Resveratrol and quercetin, two naturalpolyphenols, reduce apoptotic neuronal cell death induced byneuroinflammation. J Neurosci Res 2008; 6: 403-410.
39. Leiro J, Cano E, Ubeira FM, Orallo F, Sanmartín ML. In vitro effects ofresveratrol on the viability and infectivity of the microsporidianEncephalitozoon cuniculi. Antimicrob Agents Chemother 2004; 48: 2497-2501.
40. Shakibaei M, Harikumar KB, Aggarwal BB. Resveratrol addiction: to die ornot to die. Mol Nutr Food Res 2009; 53: 115-128.
41. Cheynier V. Polyphenols in foods are more complex than often thought. AmJ Clin Nutr 2005; 81: 223S-29.
42. Halliwell B. Are polyphenols antioxidants or pro-oxidants? What do welearn from cell culture and in vivo studies? Arch Biochem Biophys 2008;476: 107-112.
43. Birgit H. Nutrients and phytochemicals: from bioavailability to bioefficacybeyond antioxidants. Curr Opin Biotechnol 2008; 19: 73-82.
44. Kroon PA, Clifford MN, Crozier A, Day AJ, Donovan JL, Manach C, et al. How should we assess the effects of exposure to dietary polyphenols invitro? Am J Clin Nutr 2004; 80: 15-21.
45. Zhou SF, Xue CC, Yu XQ and Wang G. Metabolic activation of herbal anddietary constituents and its clinical and toxicological implications: an update.Curr Drug Metab 2007; 8: 526-553.
46. Vitrac X, Desmouliere A, Brouillaud B, Krisa S, Deffieux G, Barthe N, et al. Distribution of [14C]-trans-resveratrol, a cancer chemopreventivepolyphenol, in mouse tissues after oral administration. Life Sci 2003; 72:2219-2233.
47. Pervaiz S, Holme AL, Aggarwal BB, Anekonda TS, Baur JA, Gojkovic-Bukarica L, et al. Resveratrol: its biologic targets and functional activity.Antioxid Redox Signal 2009; 11: 2851-2897.
48. Baliga MS, Meleth S, Katiyar SK. Growth inhibitory and antimetastaticeffect of green tea polyphenols on metastasis-specific mouse mammarycarcinoma 4T1 cells in vitro and in vivo systems. Clin Cancer Res 2005; 11:1918-1927.
49. Punathil T, Tollefsbol TO, Katiyar SK. EGCG inhibits mammary cancer cellmigration through inhibition of nitric oxide synthase and guanylate cyclase.Biochem Biophys Res Commun 2008; 375: 162-167.
50. Jadeski LC, Chakraborty C, Lala PK. Nitric oxide-mediated promotion ofmammary tumour cell migration requires sequential activation of nitric oxidesynthase, guanylate cyclase and mitogen-activated protein kinase. Int JCancer 2003; 106: 496-504.
51. Winterbone MS, Tribolo S, Needs PW, Kroon PA, Hughes DA. Physiologically relevant metabolites of quercetin have no effect on adhesionmolecule or chemokine expression in human vascular smooth muscle cells. Atherosclerosis 2009; 202: 431-38.
52. Saul N, Pietsch K, Menzel R, Steinberg CE. Quercetin-mediated longevity inCaenorhabditis elegans: is DAF-16 involved? Mech Ageing Dev 2008; 129:611-3.
53. Boots AW, Haenen GR, Bast A. Health effects of quercetin: from antioxidantto nutraceutical. Eur J Pharmacol 2008; 585: 325-37.
54. Chen D, Dou QP. Tea polyphenols and their roles in cancer prevention andchemotherapy. Int J Mol Sci 2008; 9: 1196-206.
55. Ritz MF, Ratajczak P, Curin Y, Cam E, Mendelowitsch A, Pinet F, et al. Chronic treatment with red wine polyphenol compounds mediatesneuroprotection in a rat model of ischemic cerebral stroke. J Nutr 2008; 138:519-525.
56. Yazawa K, Kihara T, Shen H, Shimmyo Y, Niidome T, Sugimoto H. Distinctmechanisms underlie distinct polyphenol-induced neuroprotection. FEBSLett 2006; 580: 6623-6628.
57. Lau FC, Shukitt-Hale B, Joseph JA. Beneficial effects of berry fruitpolyphenols on neuronal and behavioral aging. J Sci Food Agric 2006; 86:2251-2255.
58. Vingtdeux V, Dreses-Werringloer U, Zhao H, Davies P, Marambaud P. Therapeutic potential of resveratrol in Alzheimer's disease. BMC Neurosci 2008; 9: S6.
59. Ramassamy C. Emerging role of polyphenolic compounds in the treatment ofneurodegenerative diseases: a review of their intracellular targets. Eur J ClinPharmacol 2006; 545: 51-64.
60. Perron NR, Brumaghim JL. A review of the antioxidant mechanisms ofpolyphenol compounds related to iron binding. Cell Biochem Biophys 2009;53: 75-100.
61. Saunders LR, Verdin E. Stress response and aging. Science 2009; 323: 1021-1022.
62. Huang J, Gan Q, Han L, Li J, Zhang H, Sun Y, et al. SIRT1 overexpressionantagonizes cellular senescence with activated ERK/S6k1 signaling in humandiploid fibroblasts. PLoS One 2008; 3: e1710.
63. Han YS, Bastianetto S, Dumont Y, Quirion R. Specific plasma membranebinding sites for polyphenols, including resveratrol, in the rat brain. JPharmacol Exp Ther 2006; 318: 238-245.
64. Radkar V, Lau-Cam C, Hardej D, Billack B. The role of surface receptorstimulation on the cytotoxicity of resveratrol to macrophages. Food ChemToxicol 2008; 46: 3664-3670.
65. Bastianetto S, Brouillette J, Quirion R. Neuroprotective effects of naturalproducts: interaction with intracellular kinases, amyloid peptides and apossible role for transthyretin. Neurochem Res 2007; 32: 1720-1725.
66. Stein TD, Anders NJ, DeCarli C, Chan SL, Mattson MP, Johnson JA.Neutralization of transthyretin reverses the neuroprotective effects ofsecreted amyloid precursor protein (APP) in APPSW mice resulting in tauphosphorylation and loss of hippocampal neurons: support for the amyloidhypothesis. J Neurosci 2004; 24: 7707-7717.
67. Bastianetto S, Dumont Y, Han Y, Quirion R. Comparative neuroprotectiveproperties of stilbene and catechin analogs: action via a plasma membranereceptor site? CNS Neurosci Ther 2009; 15: 76-83.
68. Mandel SA, Amit T, Weinreb O, Reznichenko L, Youdim MB. Simultaneousmanipulation of multiple brain targets by green tea catechins: a potentialneuroprotective strategy for Alzheimer and Parkinson diseases. CNSNeurosci Ther 2008; 14: 352-365.
69. Papiez MA, Kaja M, Gebarowska A. Age-dependent different action ofcurcumin in thyroid of rat. Folia Histochem Cytobiol 2008; 46: 205-211.
70. D'Archivio M, Santangelo C, Scazzocchio B, Varì R, Filesi C, Masella R, etal. Modulatory effects of polyphenols on apoptosis induction: relevance forcancer prevention. Int J Mol Sci 2008; 9: 213-228.
71. Okawara M, Katsuki H, Kurimoto E, Shibata H, Kume T, Akaike A.Resveratrol protects dopaminergic neurons in midbrain slice culture frommultiple insults. Biochem Pharmacol 2007; 73: 550-560.
72. Alcaín FJ, Villalba JM. Sirtuin activators. Expert Opin Ther Pat 2009; 19:403-414.
73. Chaudhary N, Pfluger PT. Metabolic benefits from Sirt1 and Sirt1 activators.Curr Opin Clin Nutr Metab Care 2009; 12: 431-437.
74. Michishita E, Park JY, Burneskis JM, Barrett JC, Horikawa I. Evolutionarilyconserved and nonconserved cellular localizations and functions of humanSIRT proteins. Mol Biol Cell 2005; 16: 4623-4635.
75. Smith JJ, Kenney RD, Gagne DJ, Frushour BP, Ladd W, Galonek HL, et al. Small molecule activators of SIRT1 replicate signaling pathways triggeredby calorie restriction in vivo. BMC Syst Biol 2009; 3: 31.
76. Fontana L. The scientific basis of caloric restriction leading to longer life.Curr Opin Gastroenterol 2009; 25: 144-150.
77. Lee KP, Simpson SJ, Clissold FJ, Brooks R, Ballard JW, Taylor PW, et al. Lifespan and reproduction in Drosophila: New insights from nutritionalgeometry. Proc Natl Acad Sci USA 2008; 105: 2498-2503.
78. Maklakov AA, Simpson SJ, Zajitschek F, Hall MD, Dessmann J, Clissold F, et al. Sex-specific fitness effects of nutrient intake on reproduction andlifespan. Curr Biol 2008; 18: 1062-1066.
79. Jiang WJ. Sirtuins: novel targets for metabolic disease in drug development. Biochem Biophys Res Commun 2008; 373: 341-344.
80. Fan E, Zhang L, Jiang S, Bai Y. Beneficial effects of resveratrol onatherosclerosis. J Med Food 2008; 11: 610-614.
81. Tan Y, Lim LH. trans-Resveratrol, an extract of red wine, inhibits humaneosinophil activation and degranulation. Br J Pharmacol 2008; 155: 995-1004.
82. Zhu J, Yong W, Wu XH, Yu Y, Lv J, Liu C, et al. Anti-inflammatory effectof resveratrol on TNF-α-induced MCP-1 expression in adipocytes. BiochemBiophys Res Commun 2008; 369: 471-477.
83. Tyagi A, Agarwal R, Agarwal C. Grape seed extract inhibits EGF-inducedand constitutively active mitogenic signaling but activates JNK in humanprostate carcinoma DU145 cells: possible role in antiproliferation andapoptosis. Oncogene 2003; 22: 1302-1316
84. Sah JF, Balasubramanian S, Eckert RL, Rorke EA. Epigallocatechin-3-gallate inhibits epidermal growth factor receptor signaling pathway.Evidence for direct inhibition of ERK1/2 and AKT kinases. J Biol Chem 2004; 279: 12755-12762.
85. Devika PT, Prince PS. Preventive effect of (-)epigallocatechin-gallate(EGCG) on lysosomal enzymes in heart and subcellular fractions inisoproterenol-induced myocardial infarcted Wistar rats. Chem Biol Interact 2008; 172: 245-252.
86. Wolfram S. Effects of green tea and EGCG on cardiovascular and metabolichealth. J Am Coll Nutr 2007; 26: 373S-388S.
87. Kromhout D. Diet and cardiovascular diseases. J Nutr Health Aging 2001; 5:144-149.
88. Basu A, Lucas EA. Mechanisms and effects of green tea on cardiovascularhealth. Nutr Rev 2007; 65: 361-375.
89. Abboud PA, Hake PW, Burroughs TJ, Odoms K, O'Connor M, MangeshkarP, et al. Therapeutic effect of epigallocatechin-3-gallate in a mouse model ofcolitis. Eur J Pharmacol 2008; 579: 411-417.
90. Madeira SV, Auger C, Anselm E, Chataigreu M, Chataigneau T, Soares de Moura R, et al. eNOS activation induced by a polyphenol-rich grape skinextract in porcine coronary arteries. J Vasc Res 2009; 46: 406-416.
91. Gresele P, Pignatelli P, Guglielmini G, Carnevale R, Mezzasoma AM,Ghiselli A, et al. Resveratrol, at concentrations attainable with moderatewine consumption, stimulates human platelet nitric oxide production. J Nutr 2008; 138: 1602-1608.
92. Anselm E, Chataigneau M, Ndiaye M, Chataigneau T, Schini-Kerth VB.Grape juice causes endothelium-dependent relaxation via a redox-sensitiveSrc- and Akt-dependent activation of eNOS. Cardiovasc Res 2007; 73: 404-413.
93. Yamakuchi M, Bao C, Ferlito M, Lowenstein CJ. Epigallocatechin gallateinhibits endothelial exocytosis. Biol Chem 2008; 389: 935-941.
94. Insull W Jr. The pathology of atherosclerosis: plaque development andplaque responses to medical treatment. Am J Med 2009; 122: S3-S14.
95. Armitage P, Doll R. The age distribution of cancer and a multi-stage theoryof carcinogenosis. Int J Epidemiol 2004; 33: 1174-1179.
96. Falk GW. Risk factors for esophageal cancer development. Surg Oncol ClinN Am 2009; 18: 469-485.
97. Lee SA, Shu XO, Li H, Yang G, Cai H, Wen W, et al. Adolescent and adultsoy food intake and breast cancer risk: results from the Shanghai Women'sHealth Study. Am J Clin Nutr 2009; 89: 1920-1926.
98. He S, Sun C, Pan Y. Red wine polyphenols for cancer prevention. Int J MolSci 2008; 9: 842-853.
99. Liu L, Lai CQ, Nie L, Ordovas J, Band M, Moser L, et al. The modulation ofendothelial cell gene expression by green tea polyphenol-EGCG. Mol NutrFood Res 2008; 52: 1182-1192.
100. Shankar S, Ganapathy S, Hingorani SR, Srivastava RK. EGCG inhibitsgrowth, invasion, angiogenesis and metastasis of pancreatic cancer. FrontBiosci 2008; 13: 440-452.
101. Kushima Y, Iida K, Nagaoka Y, Kawaratani Y, Shirahama T, Sakaguchi M, et al. Inhibitory effect of (-)-epigallocatechin and (-)-epigallocatechin gallateagainst heregulin β1-induced migration/invasion of the MCF-7 breastcarcinoma cell line. Biol Pharm Bull 2009; 32: 899-904.
102. Gu B, Ding Q, Xia G, Fang Z. EGCG inhibits growth and induces apoptosisin renal cell carcinoma through TFPI-2 overexpression. Oncol Rep 2009; 21:635-640.
103. Rhee J, Hoff PM. Angiogenesis inhibitors in the treatment of cancer. ExpertOpin Pharmacother 2005; 6: 1701-1711.
104. Folkman J. Angiogenesis: an organizing principle for drug discovery? NatRev Drug Discov 2007; 6: 273-286.
105. Khan N, Afaq F, Saleem M, Ahmad N, Mukhtar H. Targeting multiplesignaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate.Cancer Res 2006; 66: 2500-505.
106. Bergers G, Hanahan D. Modes of resistance to anti-angiogenic therapy. NatRev Cancer 2008; 8: 592-603.